Pharma Llc Tactic serves as Executive at Monopar Therapeutics, where they oversee executive responsibilities. Since joining the company, Pharma Llc Tactic has executed 6 insider transactions totaling $36.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 24, 2025 involved selling 550,229 shares valued at $35.0M.
Pharma Llc Tactic currently holds 272,026 shares of Monopar Therapeutics (MNPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma Llc Tactic has been a net seller of MNPR stock. They have purchased $0 and sold $36.8M worth of shares.
Pharma Llc Tactic's most recent insider trade was on Sep 24, 2025, when they sold 550,229 shares at $63.61 per share.
Get notified when new Form 4 filings are submitted
| $16.44 |
| Discretionary |
| Feb 11, 2021 | MNPR | $453.5K | Sale | 29,996 | $15.12 | Discretionary |
| Feb 11, 2021 | MNPR | $564.8K | Sale | 42,467 | $13.30 | Discretionary |
| Feb 11, 2021 | MNPR | $201.6K | Sale | 11,929 | $16.90 | Discretionary |
| Feb 11, 2021 | MNPR | $341.3K | Sale | 24,224 | $14.09 | Discretionary |